Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06606028 · ClinicalTrials.gov registry record
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
A clinical trial of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC), sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT06606028: Recruiting study of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC), sponsored by University of California, San Francisco.
NCT06606028 is a study of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 250 participants, above the 164-participant average among 37 other Squamous Cell Carcinoma of Head and Neck trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06606028, a study of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC), is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for participants with squamous cell carcinomas (HNC) of the head and neck mucosa and skin after curative-intent primary radiation or surgery.
Primary Outcome
Cumulative incidence will be estimated by evaluating the cumulative incidence of positive ctDNA (non-zero) with death as a competing risk.
Conditions Studied
Interventions
- PROCEDURE Blood Specimen Collection
- OTHER Medical Record Review
- PROCEDURE Tumor Tissue Collection
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-10-09 |
| Est. Completion | 2029-12-30 |
What NCT06606028 shows while recruiting
NCT06606028 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 164-participant average among 37 other Squamous Cell Carcinoma of Head and Neck trials with a reported enrollment target (52% higher).
The record links to 4 conditions, with Squamous Cell Carcinoma of Head and Neck appearing as the primary indexed condition, and to 3 interventions - of which Blood Specimen Collection is the first listed.
NCT06606028 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06606028 about?
NCT06606028 is a clinical study titled "Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma". This is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for participants with squamous cell carcinomas (HNC) of the head and neck mucosa and skin after curative-intent primary radiation or surgery.
What is the current status of trial NCT06606028?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-10-09. Estimated completion is 2029-12-30.
What conditions does trial NCT06606028 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma of Head and Neck, Cutaneous Squamous Cell Carcinoma (CSCC), Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Squamous Cell Carcinoma of Skin.
What interventions are being tested in trial NCT06606028?
The interventions under investigation include: Blood Specimen Collection (PROCEDURE), Medical Record Review (OTHER), Tumor Tissue Collection (PROCEDURE).
Who is sponsoring clinical trial NCT06606028?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06606028 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma of Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06606028's enrollment target sits among peer trials
250 7th of 37 higher than 30 of 37 other Squamous Cell Carcinoma of Head and Neck trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Squamous Cell Carcinoma of Head and Neck trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
RECRUITING · Phase 1
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of MGC026 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
RECRUITING · Phase 2
-
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RECRUITING · Phase 3
-
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI